Dr. Allison Dupuy is a Partner and Member of the Board at Simon-Kucher. She has been at the firm for more than 16 years and serves as Co-Managing Director of all operations in the USA and Head of Simon-Kucher's Healthcare & Life Sciences practice in the Americas. She is a trusted advisor to leading pharmaceutical and biotech companies across a wide range of therapeutic areas with a specialization in oncology and rare diseases and has extensive experience in the launch and commercialization of cell and gene therapies.
As one of the top executives in global healthcare consulting, Dr. Dupuy supports her clients in strategic pharmaceutical marketing, value-to-customer, product lifecycle strategies, and licensing and valuation. She is also regarded as a global leader in innovative pricing and market access strategies, market forecasting, and value communication.
Simon-Kucher is a global consultancy with more than 2,000 employees in 30 countries. The firm’s globally recognized Healthcare & Life Sciences practice has led the way in the industry for nearly 40 years, helping pharmaceutical, medical technology, and consumer healthcare companies identify, enhance, and realize the true value of their innovations.
Throughout the tenure of Dr. Dupuy’s role as a member of Simon-Kucher’s Healthcare & Life Sciences leadership team, the practice has earned a reputation for its hands-on approach and expertise. From analyzing data to developing the right roadmap to tackle clients’ issues, Dr. Dupuy and her team are passionate about unlocking growth opportunities and helping commercialize innovations that improve patient health and wellbeing.
Dr. Dupuy received her Ph.D. and M.Phil. in Molecular Biophysics and Biochemistry from Yale University as an Anne M. Briscoe Fellow and a B.A. in Physics with honors from Wellesley College, where she was a Goldwater Scholar and a Schiff Fellow.
